Ticker Details
Rein Therapeutics, Inc. Common Stock
IPO Date:	August 26, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$85.35M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.08 | 5.00%
Avg Daily Range (30 D):	$0.04 | 4.16%
Avg Daily Range (90 D):	$0.06 | 4.65%

Institutional Daily Volume
Avg Daily Volume:	.1M
Avg Daily Volume (30 D):	.49M
Avg Daily Volume (90 D):	.53M

Trade Size
Avg Trade Size (Sh.):	216
Avg Trade Size (Sh.) (30 D):	226
Avg Trade Size (Sh.) (90 D):	285

Institutional Trades
Total Institutional Trades:	4
Avg Institutional Trade:	$1.01M
Avg Institutional Trade (30 D):	$1.35M
Avg Institutional Trade (90 D):	$1.39M
Avg Institutional Trade Volume:	.96M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.39M
Avg Closing Trade (30 D):	$1.35M
Avg Closing Trade (90 D):	$1.39M
Avg Closing Volume:	1.43M

News

May 18, 2026 @ 12:00 PM Rein Therapeutics Announces Closing of $57.5 Milli... Source: Na

May 1, 2026 @ 12:00 AM Rein Therapeutics Announces Pricing of $50 Million... Source: Na

Feb 9, 2026 @ 6:00 PM Idiopathic Pulmonary Fibrosis Clinical Trials & Pi... Source: Delveinsight

Aug 19, 2025 @ 12:00 PM Rein Therapeutics Wins U.K. Approval to Launch Pha... Source: Rein Therapeutics

Aug 14, 2025 @ 9:00 PM Rein Therapeutics to Present Novel IPF Science and... Source: Rein Therapeutics

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.19	$-1.22	$-1.96
Diluted EPS	$-.19	$-1.22	$-1.96
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-5.84M	$-31.97M	$-49.87M
Operating Income / Loss	$-5.23M	$-32.66M	$-50.63M
Cost of Revenue
Net Cash Flow	$M	$.02M	$.04M
PE Ratio